Issues in long-term opioid therapy: unmet needs, risks, and solutions.
about
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challengesThe downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathwaysNeurobiology of aversive states.Attentional bias for prescription opioid cues among opioid dependent chronic pain patientsPhysician introduction to opioids for pain among patients with opioid dependence and depressive symptomsEscitalopram is associated with reductions in pain severity and pain interference in opioid dependent patients with depressive symptoms.Will abuse-deterrent formulations of opioid analgesics be successful in achieving their purpose?Development of dependence following treatment with opioid analgesics for pain relief: a systematic review.Opioid misuse behaviors in adolescents and young adults in a hematology/oncology setting.Exploring the lived experience of adults using prescription opioids to manage chronic noncancer painUndocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patientsThe health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitabilityRewarding electrical brain stimulation in rats after peripheral nerve injury: decreased facilitation by commonly abused prescription opioidsAn exploration of opioid medication management for non-malignant pain in primary care.Dependence and addiction during chronic opioid therapy.Evaluation of a novel topical essential oxygen oil for the treatment of pain in acute tendinopathy and sprains.Randomized, double-blind, placebo-controlled and active-controlled study to assess the relative abuse potential of oxycodone HCl-niacin tablets compared with oxycodone alone in nondependent, recreational opioid users.Legal liability perspectives on abuse-deterrent opioids in the treatment of chronic pain.Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing.Managing pain in inflammatory bowel disease.Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain.Current approaches in tamper-resistant and abuse-deterrent formulations.Assessing cancer pain.Abuse-deterrent formulations: part 1 - development of a formulation-based classification system.Experience with an extended-release opioid formulation designed to reduce abuse liability in a community-based pain management clinic.Comparative effectiveness in pain-related outcomes and health care utilizations between veterans with major depressive disorder treated with duloxetine and other antidepressants: a retrospective propensity score-matched comparison.Implementing an opioid risk assessment telephone clinic: Outcomes from a pharmacist-led initiative in a large Veterans Health Administration primary care clinic, December 15, 2014-March 31, 2015.Opioids, pain and addiction - practical strategies.A text-mining analysis of the public's reactions to the opioid crisis.Contemporary clinical opioid use: opportunities and challenges.Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia.Making opioid prescribing safer: time for a checklist?Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness.Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts.A multifaceted initiative to improve clinician awareness of pain management disparities.From mundane medicines to euphorigenic drugs: How pharmaceutical pleasures are initiated, foregrounded, and made durable.Chemical coping versus pseudoaddiction in patients with cancer pain.
P2860
Q24627422-5B8383ED-C17E-4EFB-8D67-EF3B56AAE7C5Q26824011-9653BD39-DA25-4237-AE53-CB29B65AE133Q27687846-4ECF8309-CEDF-4B59-863B-FE0C0BB43FF4Q30424153-0248767C-BF08-4351-84B7-AA18FF1BF493Q33667899-79ED195C-7CFB-446B-AAB9-02F78FC75C84Q34021146-EAB6776D-D59F-4F7D-AE67-E663C6381ED0Q34296600-80A68BA4-6BC6-4143-B3DE-A233E4C5B784Q34330919-D11FB75A-9467-4CE0-A319-81F6D36B4744Q34363581-E7DC5644-5A40-4C09-AB71-D68AAA516565Q35077169-7B3F2BC2-77CA-4E1B-BDA7-26FF0D514571Q35082479-DCF966F5-8B9C-415D-B64F-CB5528FADFF4Q35209803-3DE423A1-181C-47E3-BDD4-BAC814CADC48Q35580984-43F78DB6-AABC-4168-B1E8-A43D4BD3FD40Q36196260-2C8AF2B8-6930-47D5-9CC1-547E6AC6E351Q36549035-D4275656-29FF-4304-B503-8ADC1B5441F1Q36883397-76467E20-C54B-47E9-A780-BCE67861D25CQ37457193-99611A92-3726-4BB0-9201-C5506CF47B5DQ37816422-69B5C11E-91FC-4A2F-936A-9968C9E55966Q37862258-A8C7EACE-DAEA-4A5F-B120-0025E4B7D6BCQ37980743-E37E9EFD-897D-4488-A276-32DBA518C039Q37987196-3F1BFE29-A8F6-4A88-A88C-12FB802CAD3EQ38005778-9B0BE05B-9C74-476F-B672-3CB54D7940EDQ38010084-2F3FA43A-0A7F-4167-A59A-3F510DC049DCQ38265486-F1354417-8FCE-4637-AE96-C770995468CAQ38905036-BA1999D9-8527-493A-9BCD-3BB2FADD95D2Q39456635-D10E4C5D-B78A-4023-B0F2-BE9A7BACD572Q40203896-C5D80F79-4994-48B5-8F7D-1220813EA991Q41528169-E574B8E7-148D-4593-9700-66EBD5CB77B4Q42011963-A2D56C0E-5CC8-48CE-9EE6-6B3741DF817EQ42679058-F1BB84A6-0513-4C99-A0CE-21177392767EQ44338731-15DFD961-67E2-4C14-95DC-9A2E607D1985Q44343977-288114C3-783B-4631-BB09-8CA6C87C1CC9Q44344580-00CB0F4D-E1E2-43A5-B56D-CD151EBAD74AQ44344850-EF2F0507-5578-4729-B8D8-4CA33FC477B1Q44615730-A7CFA114-778F-41D3-8CC1-9C8B4F2E72CFQ47189857-520B1452-699B-4555-AC5F-EAB9D30EEE75Q47799818-EE8F7ABE-3BBF-4CFB-818F-41ECBB7607C8
P2860
Issues in long-term opioid therapy: unmet needs, risks, and solutions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Issues in long-term opioid therapy: unmet needs, risks, and solutions.
@en
Issues in long-term opioid therapy: unmet needs, risks, and solutions.
@nl
type
label
Issues in long-term opioid therapy: unmet needs, risks, and solutions.
@en
Issues in long-term opioid therapy: unmet needs, risks, and solutions.
@nl
prefLabel
Issues in long-term opioid therapy: unmet needs, risks, and solutions.
@en
Issues in long-term opioid therapy: unmet needs, risks, and solutions.
@nl
P2860
P1476
Issues in long-term opioid therapy: unmet needs, risks, and solutions.
@en
P2093
Steven D Passik
P2860
P304
P356
10.1016/S0025-6196(11)60748-9
P407
P577
2009-07-01T00:00:00Z